Neutralizing antibody to TGFβ modulates stromal fibrosis but not regression of photoablative effect following PRK

Current Eye Research

Volumn 17, Issue 7, 1998, Pages 736-747

  Møller Pedersen, Torben ^a   Cavanagh, H Dwight ^b   Petroll, W Matthew ^b   Jester, James V ^b,c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Confocal microscopy; Corneal haze; Excimer laser photorefractive keratectomy (PRK); Transforming growth factor beta (TAFB); Wound healing

Indexed keywords

ALPHA ACTIN; F ACTIN; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; ACTIN; ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA CELL; CORNEA INJURY; CORNEA STROMA; CYTOSKELETON; EXCIMER LASER; FIBROSIS; IMAGING; KERATECTOMY; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RABBIT; WOUND HEALING; ANIMAL; CORNEA; EPITHELIUM; IMMUNOLOGY; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHOTOREFRACTIVE KERATECTOMY; PHYSIOLOGY; REGENERATION; SMOOTH MUSCLE;

ACTINS; ANIMALS; ANTIBODIES; CORNEA; CORNEAL STROMA; EPITHELIUM; FIBROSIS; KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LASER; MICROSCOPY, CONFOCAL; MUSCLE, SMOOTH; RABBITS; REGENERATION; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 0031595120     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.17.7.736.5163     Document Type: Article

References (49)

1. Haviv D, Hefetz L, Krakowsky D, Abrahami S, Kibarski U, Nemet P. For how long can regression continue after photorefractive keratectomy for myopia. Ophthalmology. 1997;104:1948-1951.
2. Schallhorn SC, Blanton CL, Kaupp SE, et al. Preliminary results of photorefractive keratectomy in active-duty United States navy personnel. Ophthalmology. 1996;103:5-21.
3. Sher NA, Hardten DR, Fundingsland B, et al. 193-nm excimer photorefractive keratectomy in high myopia. Ophthalmology. 1994;101:1575-1582.
4. Gartry DS, Kerr Muir MG, Marshall J. Excimer laser photorefractive keratectomy. 18-month follow-up. Ophthalmology. 1992;99:1209-1219.
5. Dutt S, Steinert RF, Raizman MB, Puliafito CA. One-year results of excimer laser photorefractive keratectomy for low to moderate myopia. Arch Ophthalmol. 1994;112:1427-1436.
6. Maguen E, Salz JJ, Nesburn AB, et al. Results of excimer laser photorefractive keratectomy for the correction of myopia. Ophthalmology. 101;1994:1548-1556.
7. Tengroth B, Epstein D, Fagerholm P, Hamberg Nystrom H, Fitzsimmons TD. Excimer laser photorefractive keratectomy for myopia. Clinical results in sighted eyes. Ophthalmology. 1993;100:739-745.
8. Piebenga LW, Matta CS, Deitz, MR, Tauber J. Two-zone excimer photorefrective keratectomy for moderate myopia. Ophthalmology. 1995;102:1054-1059.
9. Talley AR, Hardten DR, Sher NA, et al. Results one year after using the 193-nm excimer laser for photorefractive keratectomy in mild to moderate myopia. Am J Ophthalmol. 1994:118:304-311.
10. Kim JH, Hahn TW, Lee YC, Joo CK, Sah WJ. Photorefractive keratectomy in 202 myopic eyes: one year results. Refract Corneal Surg. 1993;9:S11-S16.
11. Brancato R, Tavola A, Carones F, et al. Excimer laser photorefractive keratectomy for myopia: results in 1165 eyes. Italian Study Group. Refract Corneal Surg. 1993;9:95-104.
12. Seiler T, Holschbach A, Derse M, Jean B, Genth U. Complications of myopic photorefractive keratectomy with the excimer laser. Ophthalmology. 1994;101:153-160.
13. Ohji M, SundarRaj N, Thoft RA. Transforming growth factor-beta stimulates collagen and fibronectin synthesis by human corneal stromal fibroblasts in vitro. Curr Eye Res. 1993;12:703-709.
14. Grant MB, Khaw PT, Schultz GS, Adams JL, Shimizu RW. Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-beta on corneal cell chemotaxis. Invest Ophthalmol Vis Sci. 1992;33:3292-3301.
15. Jester JV, Barry-Lane PA, Cavanagh HD, Petroll WM. Induction of alfa-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea. 1996;15:505-516.
16. Girard MT, Matsubara M, Fini ME. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci. 1991;32:2441-2454.
17. Jester JV, Barry-Lane PA, Petroll WM, Olsen DR, Cavanagh HD. Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF-beta in the rabbit. Cornea. 1997;16:177-187.
18. Vesaluoma M, Teppo AM, Gronhagen-Riska C, Tervo T. Release of TGF-beta1 and VEGF in tears following photorefractive keratectomy. Curr Eye Res. 1997;16:19-25.
19. Dasch JR, Pace DR, Waegell W, Inenaga D, Ellingsworth L. Monoclonal antibodies recognizing transforming growth factor-beta: bioactivity neutralization and transforming growth factor beta2 affinity purification. J Immunol. 1989; 142:1536-1541.
20. Li HF, Petroll WM, Møller-Pedersen T, Maurer JK, Cavanagh HD, Jester JV. Epithelial and corneal thickness measurements by in vivo confocal microscopy through focusing (CMTF). Curr Eye Res. 1997;16:214-221.
21. Møller-Pedersen T, Vogel M, Li HF, Petroll WM, Cavanagh HD, Jester JV. Quantification of stromal thinning, epithelial thickness, and corneal haze following photorefractive keratectomy using in vivo confocal microscopy. Ophthalmology. 1997;104:360-368.
22. Møller-Pedersen T, Li HF, Petroll WM, Cavanagh HD, Jester JV. Confocal microscopic characterization of wound repair following photorefractive keratectomy. Invest Ophthalmol Vis Sci. 1998;39:487-501.
23. ARVO statement for the use of animals in ophthalmic and vision research. Invest Ophthalmol Vis Sci. 1997;38:v-vii.
24. Jester JV, Petroll WM, Barry PA, Cavanagh HD. Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest Ophthalmol Vis Sci. 1995;36:809-819.
25. Ichijima H, Petroll WM, Barry PA, et al. Actin filament organization during endothelial wound healing in the rabbit cornea: comparison between transcorneal freeze and mechanical scrape injuries. Invest Ophthalmol Vis Sci. 1993;34:2803-2812.
26. Jester JV, Barry PA, Lind GJ, Petroll WM, Garana R, Cavanagh HD. Corneal keratocytes: in situ and in vitro organization of cytoskeletal contractile proteins. Invest Ophthalmol Vis Sci. 1994;35:730-743.
27. Munnerlyn CR, Koons SJ, Marshall J. Photorefractive keratectomy: a technique for laser refractive surgery. J Cataract Refract Surg. 1988;14:46-52.
28. Colliac JP, Shammas HJ, Bart DJ. Photorefractive keratectomy for the correction of myopia and astigmatism. Am J Ophthalmol. 1994;117:369-380.
29. Davison PF, Galbavy EJ. Connective tissue remodeling in corneal and scierai wounds. Invest Ophthalmol Vis Sci. 1986;27:1478-1484.
30. Amm M, Wetzel W, Winter M, Uthoff D, Duncker GI.W. Histopathological comparison of photorefractive keratectomy and laser in situ keratomileusis in rabbits. J Refract Surg. 1996:12:758-766.
31. Talamo JH, Gollamudi S, Green WR, De La Cruz Z, Filatov V, Stark WJ. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol. 1991;109:1141-1146.
32. Tuft SJ, Zabel RW, Marshall J. Corneal repair following keratectomy. A comparison between conventional surgery and laser photoablation. Invest Ophthalmol Vis Sci. 1989; 30:1769-1777.
33. Ramirez-Florez S, Maurice DM. Inflammatory cells, refractive regression, and haze after excimer laser PRK. J Refract Surg. 1996;12:370-381.
34. Shieh E, Moreira H, D'Arcy J, Clapham TN, McDonnell PJ. Quantitative analysis of wound healing after cylindrical and spherical excimer laser ablations. Ophthalmology. 1992;99:1050-1055.
35. Goodman GL, Trokel SL, Stark WJ, Munnerlyn CR, Green WR. Corneal healing following laser refractive keratectomy. Arch Ophthalmol. 1989;107:799-803.
36. Petroll WM, Cavanagh HD, Jester JV. Three-dimensional imaging of corneal cells using in vivo confocal microscopy. J Microsc. 1993;170:213-219.
37. Petroll WM, Jester JV, Cavanagh HD. In vivo confocal imaging: general principles and applications. Scanning. 1994; 16:131-149.
38. Petroll WM, Jester JV, Cavanagh HD. Quantitative three-dimensional confocal imaging of the cornea in situ and in vivo: system design and calibration. Scanning. 1996;18:45-49.
39. Jester JV, Maurer JK, Petroll WM, Wilkie DA, Parker RD, Cavanagh HD. Application of in vivo confocal microscopy to the understanding of surfactant-induced ocular irritation. Toxicol Pathol. 1996;24:412-428.
40. Jester JV, Li HF, Petroll WM, et al. Area and depth of surfactant-induced corneal injury correlates with cell death. Invest Ophthalmol Vis Sci. 1998;38 (in Press).
41. Essepian JP, Rajpal RK, Azar DT, et al. The use of confocal microscopy in evaluating corneal wound healing after excimer laser keratectomy. Scanning. 1994;16:300-304.
42. Chew SJ, Beuerman RW, Kaufman HE, McDonald MB. In vivo confocal microscopy of corneal wound healing after excimer laser photorefractive keratectomy. CLAO J. 1995; 21:273-280.
43. Ichijima H, Petroll WM, Jester JV, et al. In vivo confocal microscopic studies of endothelial wound healing in rabbit cornea. Cornea. 1993;12:369-378.
44. Wolter JR. Reactions of the cellular elements of the corneal stroma. Arch Ophthalmol. 1958;59:873-881.
45. Kitano S, Goldman JN. Cytologic and histochemical changes in corneal wound repair. Arch Ophthalmol. 1966;76:345-354.
46. Jester JV, Petroll WM, Barry PA, Cavanagh HD. Temporal, 3-dimensional, cellular anatomy of corneal wound tissue. J Anat. 1995;186:301-311.
47. Abad JC, Lim JE, Talamo JH. Refractive regression after excimer laser photorefractive keratectomy. J Refract Surg. 1996;12:757.
48. Shah M, Foreman DM, Ferguson MWJ. Neutralisation of TGF-beta1 and TGF-beta2 or exogenous addition of TGF-beta3 to cutaneous rat wounds reduces scarring. J Cell Sci. 1995;108:985-1002.
49. Shah M, Foreman DM, Ferguson MWJ. Neutralising antibody to TGF-beta1,2 reduces cutaneous scarring in adult rodents. J Cell Sci. 1994;107:1137-1157.